These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 9779909)

  • 21. Public substance abuse and managed behavioral healthcare. American Managed Behavioral Healthcare Association and National Association of State Alcohol and Drug Abuse Directors, Inc.
    Behav Healthc Tomorrow; 1999 Feb; 8(1):25-30. PubMed ID: 10346117
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Relapse among substance-abuse patients in Riyadh, Saudi Arabia.
    al-Nahedh N
    East Mediterr Health J; 1999 Mar; 5(2):241-6. PubMed ID: 10793799
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Treatment readmissions and criminal recidivism in youth following participation in chemical dependency treatment.
    Luchansky B; He L; Longhi D; Krupski A; Stark KD
    J Addict Dis; 2006; 25(1):87-94. PubMed ID: 16597576
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Criminal recidivism in three models of mandatory drug treatment.
    Young D; Fluellen R; Belenko S
    J Subst Abuse Treat; 2004 Dec; 27(4):313-23. PubMed ID: 15610833
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Medicaid eligibility and access to mental health services among adolescents in substance abuse treatment.
    Deck D; Ley KV
    Psychiatr Serv; 2006 Feb; 57(2):263-5. PubMed ID: 16452708
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Use of substance abuse treatment services by persons with mental health and substance use problems.
    Wu LT; Ringwalt CL; Williams CE
    Psychiatr Serv; 2003 Mar; 54(3):363-9. PubMed ID: 12610245
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Managed care and the quality of substance abuse treatment.
    Shepard DS; Daley M; Ritter GA; Hodgkin D; Beinecke RH
    J Ment Health Policy Econ; 2002 Dec; 5(4):163-74. PubMed ID: 14578550
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Recidivism in alcoholism and substance abuse programs. An introduction to the symposium.
    Richman A
    Drug Alcohol Depend; 1978 May; 3(3):211-3. PubMed ID: 668493
    [No Abstract]   [Full Text] [Related]  

  • 29. Characterizing substance abuse programs that treat adolescents.
    Mark TL; Song X; Vandivort R; Duffy S; Butler J; Coffey R; Schabert VF
    J Subst Abuse Treat; 2006 Jul; 31(1):59-65. PubMed ID: 16814011
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Dual Diagnosis Capability of Residential Addiction Treatment centres: priorities and confidence to improve capability following a review process.
    Matthews H; Kelly PJ; Deane FP
    Drug Alcohol Rev; 2011 Mar; 30(2):195-9. PubMed ID: 21355921
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Patient satisfaction, use of services, and one-year outcomes in publicly funded substance abuse treatment.
    Carlson MJ; Gabriel RM
    Psychiatr Serv; 2001 Sep; 52(9):1230-6. PubMed ID: 11533398
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Documenting changes in the delivery of substance abuse services: the Status of the "100 best treatment centers for alcoholism and drug abuse" of 1988.
    Macmaster SA; Holleran LK; Chantus D; Kostyk L
    J Health Soc Policy; 2005; 20(3):67-77. PubMed ID: 16236679
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [On the outcome of the treatment of mentally disordered criminal offenders (according to section 64 German Penal Code) suffering from addictive disorders].
    Gericke B; Kallert TW
    Psychiatr Prax; 2007 Apr; 34 Suppl 2():S218-26. PubMed ID: 17394114
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Improving access to substance abuse treatment services for consumers with AIDS: a formative evaluation.
    Cooper RL; Cloud R; Besel K; Bennett AJ
    J Evid Based Soc Work; 2010 Jan; 7(1):115-29. PubMed ID: 20178029
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The costs of pursuing accreditation for methadone treatment sites: results from a national study.
    Zarkin GA; Dunlap LJ; Homsi G
    Eval Rev; 2006 Apr; 30(2):119-38. PubMed ID: 16492995
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mental health indicator interaction in predicting substance abuse treatment outcomes in nevada.
    Greenfield L; Wolf-Branigin M
    Am J Drug Alcohol Abuse; 2009; 35(5):350-7. PubMed ID: 20180663
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prison Addiction Program and the Role of Integrative Treatment and Program Completion on Recidivism.
    Haviv N; Hasisi B
    Int J Offender Ther Comp Criminol; 2019; 63(15-16):2741-2770. PubMed ID: 31510830
    [TBL] [Abstract][Full Text] [Related]  

  • 38. How drug courts reduce substance abuse recidivism.
    Torgensen K; Buttars DC; Norman SW
    J Law Med Ethics; 2004; 32(4 Suppl):69-72. PubMed ID: 15807331
    [No Abstract]   [Full Text] [Related]  

  • 39. Using concept mapping to design an indicator framework for addiction treatment centres.
    Nabitz U; van Den Brink W; Jansen P
    Int J Qual Health Care; 2005 Jun; 17(3):193-201. PubMed ID: 15831547
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Examining Individual Characteristics and Program Performance to Understand Two-Year Recidivism Rates Among Drug Court Participants: Comparing Graduates and Terminators.
    Shannon LM; Jones AJ; Newell J; Payne C
    Int J Offender Ther Comp Criminol; 2018 Oct; 62(13):4196-4220. PubMed ID: 29706118
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.